173 related articles for article (PubMed ID: 202418)
41. Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates.
Heymann DL; Murphy K; Brigaud M; Aymard M; Tembon A; Maben GK
Bull World Health Organ; 1987; 65(4):495-501. PubMed ID: 3500802
[TBL] [Abstract][Full Text] [Related]
42. Poliomyelitis: epidemiology and prophylaxis. 3. Nationwide vaccination campaign with the help of lay volunteers.
Koinange W; Rogowski JJ; Metselaar D
Bull World Health Organ; 1973 May; 48(5):543-5. PubMed ID: 4544145
[TBL] [Abstract][Full Text] [Related]
43. Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda.
Dömök I; Balayan MS; Fayinka OA; Skrtić N; Soneji AD; Harland PS
Bull World Health Organ; 1974; 51(4):333-47. PubMed ID: 4142936
[TBL] [Abstract][Full Text] [Related]
44. [Results of immunization of seronegative children with live poliomyelitis vaccine].
Babaev AA
Vopr Virusol; 1978; (5):553-6. PubMed ID: 153652
[TBL] [Abstract][Full Text] [Related]
45. [Indicators of immunity in children vaccinated with live poliomyelitis vaccine].
Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):115-7. PubMed ID: 204133
[TBL] [Abstract][Full Text] [Related]
46. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years.
Böttiger M; Zetterberg B; Salenstedt CR
Bull World Health Organ; 1972; 46(2):141-9. PubMed ID: 4537478
[TBL] [Abstract][Full Text] [Related]
47. Studies on a single-dose capsule preparation of Poliomyelitis vaccine.
Barnes JM; Galbraith NS
Bull World Health Organ; 1966; 34(5):693-9. PubMed ID: 5296232
[TBL] [Abstract][Full Text] [Related]
48. Control of a type 1 poliomyelitis epidemic in British Guiana, 1962-63, with trivalent oral poliovirus vaccine. 2. Virological aspects.
Feldman RA; Mootoo CL; Spence L; Gelfand HM
Bull World Health Organ; 1965; 33(1):13-9. PubMed ID: 4284022
[TBL] [Abstract][Full Text] [Related]
49. Coverage and causes of missed oral polio vaccine in urban and rural areas of Peshawar.
Naeem M; Adil M; Abbas SH; Khan MZ; Naz SM; Khan A; Khan MU
J Ayub Med Coll Abbottabad; 2011; 23(4):98-102. PubMed ID: 23472426
[TBL] [Abstract][Full Text] [Related]
50. [The level of herd immunity against poliomyelitis in children during the mass vaccinal prophylaxis of this infection].
Spynu KI; Buzdugan GI; Vutkarev VP
Vopr Virusol; 1986; 31(5):602-5. PubMed ID: 3026095
[TBL] [Abstract][Full Text] [Related]
51. Poliomyelitis: epidemiology and prophylaxis. 1. A longitudinal epidemiological survey in Kenya.
Nottay BK; Metselaar D
Bull World Health Organ; 1973; 48(4):421-7. PubMed ID: 4357976
[TBL] [Abstract][Full Text] [Related]
52. [Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].
Drozdov SG; Zhevandrova VI; Smirnova GA; Shmel'kov IuA; Kodkind GKh
Vopr Virusol; 1979; (3):252-9. PubMed ID: 223328
[TBL] [Abstract][Full Text] [Related]
53. [Long-term observations of dynamics of collective immunity to poliomyelitis in vaccinated children].
Seĭbil' VB; Efimova VF; Troshina LD; Ershova GA
Vopr Virusol; 1978; (1):43-7. PubMed ID: 645055
[TBL] [Abstract][Full Text] [Related]
54. [Parameters (r-value of the immunity status, cumulative vaccination participation, index of the relative vaccination participation) for the surveillance of poliomyelitis in a city of the Ruhr-area].
Höher PG; Thraenhart O; Kuwert E; Bohlmann HG; Worringen W; Lagarie GW
Zentralbl Bakteriol Orig B; 1973 Feb; 156(6):471-85. PubMed ID: 4713086
[No Abstract] [Full Text] [Related]
55. [Humoral poliomyelitis immunity in children inoculated with a live poliomyelitis vaccine].
Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
Vopr Virusol; 1984; 29(2):251-3. PubMed ID: 6328770
[No Abstract] [Full Text] [Related]
56. Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection.
John TJ
Am J Epidemiol; 1975 Nov; 102(5):414-21. PubMed ID: 1200025
[TBL] [Abstract][Full Text] [Related]
57. Outbreak of paralytic poliomyelitis, Taiwan.
Kim-Farley RJ; Rutherford G; Lichfield P; Hsu ST; Orenstein WA; Schonberger LB; Bart KJ; Lui KJ; Lin CC
Lancet; 1984 Dec; 2(8415):1322-4. PubMed ID: 6150332
[TBL] [Abstract][Full Text] [Related]
58. [State of collective immunity to poliomyelitis in Moscow donors].
Seĭbil' VB; Malyshkina LP; Lavrova IK; Efimova VF; Sadovnikova VN
Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):43-7. PubMed ID: 12506627
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of the results of serum studies of children and adults for antibodies to the poliomyelitis virus in a multiyear effort at vaccinal prevention of this infection].
Boĭko VM; Karaseva IA; Balakireva RG; Lazikova GF; Pichushkov AV
Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):78-82. PubMed ID: 6282015
[TBL] [Abstract][Full Text] [Related]
60. Immunity to poliomyelitis in Sydney's children.
Christopher PJ; Murphy AM; Armstrong MN
Med J Aust; 1983 Feb; 1(3):107-11. PubMed ID: 6571535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
